LOADING
Comparing Procter & Gamble (PG) and Thermo Fisher Scientific (TMO) across the Consumer Staples and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | PG | TMO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $336.9B | $232.5B |
| P/E Ratio | 21.8 | 33.9 |
| Forward P/E | 20.8 | 25.1 |
| PEG Ratio | 4.15 | 2.05 |
| EPS | $6.63 | $18.55 |
| Revenue Growth (YoY) | 1.5% | 10.5% |
| Profit Margin | 18.4% | 15.0% |
| Return on Equity | 30.3% | 13.5% |
| Dividend Yield | 2.98% | 0.29% |
| Beta | 0.38 | 0.85 |
| 52-Week High | $164.77 | $642.71 |
| 52-Week Low | $134.62 | $434.83 |
| Volume | -- | -- |
Procter & Gamble is the larger company by market capitalization. Procter & Gamble trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Procter & Gamble offers a higher dividend yield for income investors. Procter & Gamble has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.